Drugs / SPM 929
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00350103 | Jun 2006 → Jun 2007 | neuropathy, painful | UCB Pharma | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPM 929 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00350103 ↗ |
| Route | Oral | “Route of administration: Oral use” NCT00350103 ↗ |